SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as community members highlight its strong community, unique art, and potential for amplified gains as a meme coin on the Injective chain ($INJ.X). The community is closely watching for potential catalysts, including a possible staked $INJ.X ETF, which could further boost $NONJA.X.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin, emphasizing its fair launch and strong community, known as the #DOGArmy. Community members highlight its integration with the Bitcoin network, and some suggest it could outperform other meme coins. There is also discussion around potential exchange listings and price targets.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors anticipate the results from the global Phase III HARMONi clinical trial for Ivonescimab, which will be presented at the World Conference on Lung Cancer. Community discussions revolve around the potential for positive Overall Survival (OS) data, particularly for Western patients, and speculation about a possible Biologics License Application (BLA) filing. Some traders are also discussing the possibility of a large licensing deal with AstraZeneca, which could be a catalyst for significant upside.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a potential catalyst related to the company's land assets and a planned liquidation, sparking speculation of a significant value unlock. The stock's low float is fueling discussions about potential for a rapid price surge, with some traders eyeing a run back to previous highs. Community members are closely monitoring volume and key breakout levels, anticipating a possible squeeze.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as the community rallies around its resilience and unique reward system, which pays holders in $SOL.X. Discussions highlight the project's community-led nature, battle-tested survival, and the recent Kimbo Slice Jr. partnership. Community members are emphasizing the protocol's ability to provide tangible rewards and its potential to outperform traditional passive income methods.

Numeraire

Numeraire is trending as traders discuss a potential investment from a major US bank, which the community believes could significantly increase the token's value. Community members are closely watching key price levels, anticipating a breakout and further upward movement. The coin's AI narrative and low circulating supply contribute to the bullish sentiment.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond ($BBBY) is trending as traders discuss the reactivation of the ticker following Beyond, Inc.'s acquisition of its intellectual property, with some speculating about potential partnerships and short squeezes. The community is also debating the implications for former BBBYQ shareholders and the potential for tokenizing the stock. Bullish sentiment is fueled by discussions around blockchain applications and memories of previous squeezes.

Sapien is an open protocol for sourcing verified human knowledge at scale. Its network of millions of contributors spans more than 100 countries, ranging from doctors and engineers to artists and students. Together they produce high-quality AI training data, validated through Sapien’s onchain Proof of Quality system. This ensures enterprises and AI developers can access trusted, human-in-the-loop data while transforming fragmented online work into a sustainable, reputation-based profession. Incentives across the network are powered by the $SAPIEN token, an ERC-20 asset on Base.

Sapien

Sapien.X is trending as the community discusses its potential for significant gains, with some drawing comparisons to other recently successful tokens. The token's chart setup and appealing levels are generating interest, while others speculate about potential scams. The recent listing and overall market conditions abroad are also being mentioned as potential catalysts.

ProShares Trust - ProShares UltraPro Short Dow30 -3x Shares

ProShares UltraPro Short Dow30

ProShares UltraPro Short Dow30 ($SDOW) is trending as traders discuss potential market reversals and hedging strategies amid ongoing economic uncertainty. The community is weighing whether current market highs are sustainable, with some expressing concerns about overvaluation and potential for a significant correction. Many traders are employing $SDOW as a hedge against their long positions or betting on a market downturn, while others caution about the ETF's inherent decay and the risks of holding it long-term.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara is trending as analysts adjust price targets following recent reports, with community members debating its long-term potential and valuation.  Discussions revolve around the company's growth prospects within the IoT sector and its collaborations, particularly in the realm of fleet management and AI applications.  The stock is experiencing notable call option activity, sparking speculation about potential catalysts and future performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of medical tech company Heartflow Inc. (HTFL) surged 51% on Friday in its Nasdaq debut after the company raised nearly $317 million from its initial public offering.Heartflow’s shares traded at $28.67 at 2:00 p.m. ET on Friday, compared to a public offering price of $19 per share, and above its targeted range of $17 to $18 per share. The stock opened at $28. Its market capitalization at the time of writing stood at $2.33 billion.The Mountain View, California-based company offered 16.67 million shares of its common stock. J.P. Morgan, Morgan Stanley, and Piper Sandler acted as joint book-running managers for the offering.<a href="https://stocktwits.com/symbol/HTFL">Heartflow</a> aims to transform coronary care. Its AI analysis creates a detailed three-dimensional model of the heart, providing insights for treatment. According to the company, it has helped clinicians manage over 400,000 patients, and over 1,400 institutions are currently using Heartflow since its founding in 2010.According to <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-08-08/medical-tech-firm-heartflow-surges-66-after-317-million-ipo">Bloomberg</a>, the company reported revenue of $37.2 million and a net loss of $32.3 million for the three months through the end of March, compared with a net loss of $20.9 million on revenue of $26.8 million in the same period a year ago. The company, backed by Bain Capital, ended the quarter with $109.8 million in cash and cash equivalents.A Stocktwits user termed it the “best medtech deal in at least a decade” pre-IPO.<stembedurl>https://stocktwits.com/Knot2/message/624240194</stembedurl>Another opined that the company has something valuable to offer.<stembedurl>https://stocktwits.com/Scam_Likely/message/624209119</stembedurl>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/ani-pharma-ceo-expresses-confidence-on-trump-tariff-impact-after-guidance-lift/chrnjldRd49">ANI Pharma Stock Shoots Through The Roof On Friday: CEO’s Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Heartflow IPO: Stock Rockets On Nasdaq Debut

The shares traded at $28.18 at 1:33 p.m. ET on Friday compared to a public offering price of $19.00 per share.

Equity

The shares traded at $28.67 at 2:00 p.m. ET on Friday, compared to a public offering price of $19 per share.



HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.

HTFL
Heartflow, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest HTFL News

HTFL Heartflow, Inc.